staceywhite, Author at European Medical Journal - Page 6 of 195

Reshaping Prostate Cancer Therapies with Biomarker-Driven Strategies

TARGETED treatments for prostate cancer were a central theme at the European Society for Medical Oncology (ESMO) Congress 2025, where…

Emerging Therapeutic Frontiers in Cardiology: What Does the Future Hold?

AN ENLIGHTENING session, entitled ‘Emerging therapeutic frontiers in cardiology: what does the future hold?’, delivered at the European…

IURES Congress 2025 Interview: Erdem Canda

When we were establishing IURES, our aim was to be not only a national society but an international one. Our main goal has been to…

Renal Denervation at ESC 2025

Renal denervation (RDN) is a minimally invasive procedure used as an adjunctive treatment for individuals with resistant hypertension when…

American College of Rheumatology Convergence 2025

THE AMERICAN College of Rheumatology (ACR) Convergence returned to Chicago, Illinois, USA, this year, and with it brought thousands of…

Effectiveness of SC vs IV Natalizumab

Subcutaneous administration of natalizumab provides similar real-world effectiveness to intravenous administration, providing a convenient…

GLP-1 Receptor Agonists in Osteoarthritis

THIS YEAR, at the American College of Rheumatology (ACR) Convergence 2025, a dedicated session explored whether glucagon-like peptide-1…

ACR 2025: Next-Generation CAR-T Targets for SLE

THE AMERICAN College of Rheumatology (ACR) 2025 Convergence was an epicenter for discussion, collaboration, and celebration of the…

Twenty-five years of etanercept

Rheumatologist Rieke Alten discusses how treat-to-target care and TNF inhibition with etanercept reshape RA outcomes, with safety…

Long-Acting Therapeutics for HIV

Key takeaways from the symposia. Impact of LA options on the future of treatment and prevention. Opportunities and challenges for…